Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.6790
+0.0184 (2.79%)
Oct 2, 2026, 2:39 PM EDT - Market open

Envoy Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
52192935--
Market Cap Growth
183.79%-34.26%-18.21%---
Enterprise Value
34164029--
Last Close Price
0.660.661.431.8110.029.74

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
256.3878.97128.67112.02--
PB Ratio
13.80-1.62-1.54-19.93--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
165.2368.14178.3890.34--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.22-0.08-1.04-0.32-0.95-0.94
Net Debt / Equity Ratio
-5.110.24-0.752.06-0.95-0.89
Net Debt / EBITDA Ratio
0.820.13-0.740.20-3.98-3.29
Net Debt / FCF Ratio
0.870.15-0.750.21-3.81-3.17
Asset Turnover
0.010.020.020.060.09-
Inventory Turnover
0.520.420.480.590.42-
Quick Ratio
1.560.330.840.610.090.87
Current Ratio
1.740.541.181.020.651.76
Return on Assets (ROA)
-86.53%-137.34%-121.51%-211.96%-210.09%-
Return on Capital Employed (ROCE)
-207.10%735.00%-481.40%-1862.00%-23529.70%-554.10%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-53.62%-124.83%-71.83%-84.53%--
FCF Yield
-40.91%-96.58%-65.39%-48.72%--
Buyback Yield / Dilution
-177.04%-23.78%-52.83%-21.46%0.04%-
SEC Filings: 10-K · 10-Q